Furthermore, prevailing evidence supports higher methylation levels and decreased expression of BDNF in patients with schizophrenia, a fact that may explain the impaired GABAergic signaling and the reduced hippocampal volume observed in this cohort compared to controls [106]. Here, BDNF is linked to schizophrenia.